Drop Down Menu by: rsuitor@yahoo.com
Research & Development
Since inception the company is focused on development of novel healthcare products, especially to address medical needs that remain inadequately addressed.

Pioneering in Liposomal Technology, Lifecare Innovations has commercialized five liposomal drugs and a number of other drugs are at different stages of development and clinical trials. The most outstanding contribution of the R&D efforts of the company is . The only Amphotericin B formulation of the world that is almost free of nephrotoxicity - a formulation problem that remained unsolved for sixty years.

FUNGISOME GEL ,the only topical formulation of Amphotericin B, is effective against leishmanial, pathogenic fungi including Dermatophytes, yeasts and moulds.

The platform technology for oral sustained release nano-drugs allows designing of formulation to sustain therapeutic levels of drugs for up to fifteen days and has been applied to develop drugs for tuberculosis, malaria and cancer. The oral sustained release nano-technology has vast potentials and is available for licensing and partnering.

A new research centre at Biotechnology Park Lucknow is scheduled to be functional soon. The centre in close proximity of institutions as Central Drug Research Institute, Centre for Medicinal and Aromatic Plants, Indian Institute for Toxicology Research, Sanjay Gandhi Postgraduate Institute of Medical Sciences, S J Medical University, holds promise to make significant contributions in Drug Discovery and Development.

Home |   Fungal Infections |  Kala - Azar |  R & D  |  Management |  Press Room |  Milestones |  Career |  Order |  Enquiry |  Contact Us
  © All Rights Reserved  : Lifecare Innovations Private Limited. 

  Website is best viewed at 1024 x 768 pixels.

Powered by : Axis Softech